Skip to main content
SpringerLink
Log in

Multi-institutional melanoma vaccine trial

  • Letters To The Editor
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wallack MK, Sivanandham M, Whooley B, Ditaranto K, Bartolucci AA. Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma, vaccine trial.Ann Surg Oncol 1996;3:110–7.

    CAS  PubMed  Google Scholar 

  2. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.J Am Med Assoc 1991;266:93–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Michigan Medical Center, Ann Arbor, Michigan

    Vernon K. Sondak MD (Associate Professor of Surgery)

Authors
  1. Vernon K. Sondak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sondak, V.K. Multi-institutional melanoma vaccine trial. Annals of Surgical Oncology 3, 588–589 (1996). https://doi.org/10.1007/BF02306095

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02306095

Keywords

Search

Navigation